A foundation model for clinician-centered drug repurposing.
A new AI model, TxGNN, enhances drug repurposing accuracy for various diseases. Promising results for clinicians. 💊📈
September 26, 2024
Follow us
latest articles
Discover the newest research about AI innovations in 🧪 Drug Discovery.
PharmaBench: Enhancing ADMET benchmarks with large language models.
PharmaBench improves ADMET benchmarks using large language models, enhancing drug development accuracy. 🧬📊 Comprehensive dataset aids AI model creation.
September 21, 2024